Is Achilles Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: ACHL) stock is to Strong Buy ACHL stock.
Out of 2 analysts, 2 (100%) are recommending ACHL as a Strong Buy, 0 (0%) are recommending ACHL as a Buy, 0 (0%) are recommending ACHL as a Hold, 0 (0%) are recommending ACHL as a Sell, and 0 (0%) are recommending ACHL as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year ACHL price target, the average ACHL price target is $12.50, with the highest ACHL stock price forecast at $17.00 and the lowest ACHL stock price forecast at $8.00.
On average, Wall Street analysts predict that Achilles Therapeutics's share price could reach $12.50 by Dec 7, 2023. The average Achilles Therapeutics stock price prediction forecasts a potential upside of 1,320.45% from the current ACHL share price of $0.88.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.